Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ILSE Insider Trading

ILSE | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at ILSE provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2007-01-17 23:01 2007-01-12 LINK WILLIAM J PHD Director SELL $24.52 250,000 $6,129,800 2,156,758 -10.4%
2006-05-19 22:41 2006-05-19 Kliman Gilbert H Director SELL $19.50 2,054 $40,053 0 -100.0%
2006-05-11 21:31 2006-05-09 LINK WILLIAM J PHD Director SELL $20.33 50,000 $1,016,510 2,406,758 -2.0%
2006-05-02 03:21 2006-05-01 Kliman Gilbert H Director SELL $20.47 60,673 $1,242,274 0 -100.0%
2006-03-31 20:33 2006-03-29 Juhasz Tibor Officer - Chief Technology Officer SELL $22.03 25,100 $552,930 337,907 -6.9%
2006-03-30 17:39 2006-03-28 Juhasz Tibor Officer - Chief Technology Officer SELL $21.63 16,900 $365,569 363,007 -4.4%
2006-03-30 00:54 2006-03-27 Juhasz Tibor Officer - Chief Technology Officer SELL $21.01 8,000 $168,090 379,907 -2.1%
2006-03-23 17:44 2006-03-22 Thunen Shelley B Officer - EVP & CFO SELL $20.29 8,378 $169,951 0 -100.0%
2006-03-24 04:57 2006-03-22 Juhasz Tibor Officer - Chief Technology Officer SELL $20.20 50,000 $1,009,880 387,907 -11.4%
2006-03-18 01:17 2006-03-16 Juhasz Tibor Officer - Chief Technology Officer SELL $18.84 50,000 $941,865 437,907 -10.2%
2006-02-25 01:09 2006-02-22 Thunen Shelley B Officer - EVP & CFO SELL $19.35 1,000 $19,353 8,378 -10.7%
2006-02-25 01:09 2006-02-22 Thunen Shelley B Officer - EVP & CFO SELL $19.08 36,100 $688,640 9,378 -79.4%
2006-02-25 01:08 2006-02-22 Thunen Shelley B Officer - EVP & CFO SELL $18.64 10,900 $203,175 45,478 -19.3%
2005-12-09 17:52 2005-12-07 Juhasz Tibor Officer - Chief Technology Officer SELL $19.03 3,000 $57,100 487,907 -0.6%
2005-12-06 02:38 2005-12-02 Juhasz Tibor Officer - Chief Technology Officer SELL $18.06 5,000 $90,310 495,907 -1.0%
2005-11-23 18:58 2005-11-21 Juhasz Tibor Officer - Chief Technology Officer SELL $18.07 2,000 $36,140 500,907 -0.4%
2005-09-22 17:09 2005-09-19 Juhasz Tibor Officer - Chief Technology Officer SELL $16.01 3,000 $48,030 347,754 -0.9%
2005-09-13 21:48 2005-09-09 Juhasz Tibor Officer - Chief Technology Officer SELL $17.91 4,500 $80,588 350,754 -1.3%
2005-09-13 21:24 2005-09-06 Juhasz Tibor Officer - Chief Technology Officer SELL $17.50 3,500 $61,254 355,254 -1.0%
2005-08-31 03:45 2005-08-29 Juhasz Tibor Officer - Chief Technology Officer SELL $19.01 6,000 $114,065 358,754 -1.6%
2005-08-24 21:03 2005-08-22 Juhasz Tibor Officer - Chief Technology Officer SELL $19.23 6,000 $115,403 364,754 -1.6%
2005-08-17 17:25 2005-08-15 Juhasz Tibor Officer - Chief Technology Officer SELL $19.84 8,000 $158,691 370,754 -2.1%
2005-08-13 01:18 2005-08-11 Weinberg Eric Officer - V.P. Mktg & Prof. Affairs SELL $19.73 50,000 $986,520 92,508 -35.1%
2005-08-11 17:55 2005-08-08 Juhasz Tibor Officer - Chief Technology Officer SELL $19.33 6,000 $115,975 378,754 -1.6%
2005-08-09 23:29 2005-08-08 Kurtz Ronald M MD Officer - VP, Medical Director SELL $19.48 2,000 $38,960 243,762 -0.8%
2005-08-04 16:22 2005-08-01 Juhasz Tibor Officer - Chief Technology Officer SELL $20.62 8,000 $164,929 384,754 -2.0%
2005-08-02 03:40 2005-08-01 Kurtz Ronald M MD Officer - VP, Medical Director SELL $20.86 15,000 $312,900 245,762 -5.8%
2005-07-29 03:44 2005-07-27 Juhasz Tibor Officer - Chief Technology Officer SELL $21.89 4,700 $102,899 392,754 -1.2%
2005-07-28 21:33 2005-07-27 Kurtz Ronald M MD Officer - VP, Medical Director SELL $21.99 6,000 $131,940 260,762 -2.2%
2005-07-27 21:23 2005-07-25 Juhasz Tibor Officer - Chief Technology Officer SELL $19.07 7,800 $148,741 397,454 -1.9%
2005-07-27 20:17 2005-07-25 Kurtz Ronald M MD Officer - VP, Medical Director SELL $18.93 12,000 $227,120 266,762 -4.3%
2005-07-22 22:57 2005-07-20 Juhasz Tibor Officer - Chief Technology Officer SELL $19.06 2,000 $38,111 405,254 -0.5%
2005-07-20 22:32 2005-07-18 Juhasz Tibor Officer - Chief Technology Officer OPT+S $18.23 4,000 $72,932 407,845 0.0%
2005-07-20 01:25 2005-07-18 Kurtz Ronald M MD Officer - VP, Medical Director SELL $18.04 9,000 $162,400 278,762 -3.1%
2005-07-16 04:15 2005-07-14 Juhasz Tibor Officer - Chief Technology Officer OPT+S $20.87 3,000 $62,614 409,549 0.0%
2005-07-16 03:57 2005-07-14 Kurtz Ronald M MD Officer - VP, Medical Director SELL $20.88 3,000 $62,640 287,762 -1.0%
2005-07-15 00:53 2005-07-12 Juhasz Tibor Officer - Chief Technology Officer OPT+S $19.65 4,000 $78,599 409,549 0.0%
2005-07-13 00:45 2005-07-11 Juhasz Tibor Officer - Chief Technology Officer OPT+S $19.93 2,500 $49,814 409,549 0.0%
2005-07-12 03:28 2005-07-11 Kurtz Ronald M MD Officer - VP, Medical Director SELL $19.89 12,000 $238,620 290,762 -4.0%
2005-07-08 00:21 2005-07-05 Juhasz Tibor Officer - Chief Technology Officer OPT+S $19.86 8,000 $158,850 409,549 0.0%
2005-07-06 21:25 2005-07-05 Kurtz Ronald M MD Officer - VP, Medical Director SELL $19.93 12,000 $239,197 302,762 -3.8%
2005-07-01 03:18 2005-06-29 Juhasz Tibor Officer - Chief Technology Officer OPT+S $20.02 1,700 $34,034 409,549 0.0%
2005-06-29 02:20 2005-06-27 Juhasz Tibor Officer - Chief Technology Officer OPT+S $19.63 6,300 $123,653 409,549 0.0%
2005-06-29 01:18 2005-06-27 Kurtz Ronald M MD Officer - VP, Medical Director SELL $19.52 12,000 $234,240 314,762 -3.7%
2005-06-22 21:25 2005-06-20 Juhasz Tibor Officer - Chief Technology Officer OPT+S $19.44 6,000 $116,614 409,549 0.0%
2005-06-22 20:36 2005-06-20 Kurtz Ronald M MD Officer - VP, Medical Director SELL $19.15 9,000 $172,350 326,762 -2.7%
2005-06-17 21:10 2005-06-16 Kliman Gilbert H Director SELL $19.22 2,408 $46,282 0 -100.0%
2005-06-15 21:43 2005-06-14 Kurtz Ronald M MD Officer - VP, Medical Director SELL $19.03 18,000 $342,481 335,762 -5.1%
2004-10-15 19:48 2004-10-13 Porter Thomas S Director BUY $13.00 3,744 $48,672 3,744 +100.0%
2004-10-15 02:13 2004-10-13 Weinberg Eric Officer - VP Mktg & Prof. Affairs BUY $13.00 4,680 $60,840 4,680 +100.0%
SHOW ENTRIES

How to Interpret $ILSE Trades

Not every insider transaction in ILSE is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ILSE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ILSE

Insider activity data for ILSE is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ILSE, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.